Phase II single-arm study of palbociclib and cetuximab rechallenge in KRAS/NRAS/BRAF wild-type ( KRAS WT) metastatic colorectal cancer (mCRC) patients (pts).
Cetuximab;Palbociclib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase II single-arm study of palbociclib and cetuximab rechallenge in KRAS/NRAS/BRAF wild-type ( KRAS WT) metastatic colorectal cancer (mCRC) patients (pts). ### Output: Cetuximab;Palbociclib